Connection

PENGXIANG HUANG to Humans

This is a "connection" page, showing publications PENGXIANG HUANG has written about Humans.
Connection Strength

0.214
  1. Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism. Oncotarget. 2016 Nov 01; 7(44):71378-71389.
    View in: PubMed
    Score: 0.015
  2. Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53. Mitochondrion. 2016 Nov; 31:33-39.
    View in: PubMed
    Score: 0.015
  3. Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol. 2012; 10(5):e1001326.
    View in: PubMed
    Score: 0.011
  4. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol. 2012 Feb 19; 14(3):276-86.
    View in: PubMed
    Score: 0.011
  5. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by ?-phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxid Redox Signal. 2011 Dec 15; 15(12):2911-21.
    View in: PubMed
    Score: 0.010
  6. Metabolic alterations in cancer cells and therapeutic implications. Chin J Cancer. 2011 Aug; 30(8):508-25.
    View in: PubMed
    Score: 0.010
  7. Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity. Cancer Biol Ther. 2011 Jan 15; 11(2):150-6.
    View in: PubMed
    Score: 0.010
  8. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion. 2010 Nov; 10(6):614-25.
    View in: PubMed
    Score: 0.010
  9. Small mitochondria-targeting molecules as anti-cancer agents. Mol Aspects Med. 2010 Feb; 31(1):75-92.
    View in: PubMed
    Score: 0.009
  10. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009 Jul; 8(7):579-91.
    View in: PubMed
    Score: 0.009
  11. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol. Antioxid Redox Signal. 2009 May; 11(5):1083-95.
    View in: PubMed
    Score: 0.009
  12. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim Biophys Acta. 2009 May; 1787(5):553-60.
    View in: PubMed
    Score: 0.009
  13. Redox regulation of cell survival. Antioxid Redox Signal. 2008 Aug; 10(8):1343-74.
    View in: PubMed
    Score: 0.008
  14. Alterations of cellular redox state during NNK-induced malignant transformation and resistance to radiation. Antioxid Redox Signal. 2008 May; 10(5):951-61.
    View in: PubMed
    Score: 0.008
  15. The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr. 2007 Jun; 39(3):267-74.
    View in: PubMed
    Score: 0.008
  16. A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. Mol Pharmacol. 2006 Jul; 70(1):426-33.
    View in: PubMed
    Score: 0.007
  17. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005 Oct 05; 24(19):3482-92.
    View in: PubMed
    Score: 0.007
  18. Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. Nat Commun. 2024 Apr 11; 15(1):3149.
    View in: PubMed
    Score: 0.006
  19. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med. 2024 Mar 19; 5(3):101463.
    View in: PubMed
    Score: 0.006
  20. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science. 2023 09 08; 381(6662):eabn4180.
    View in: PubMed
    Score: 0.006
  21. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018 10; 20(10):1181-1192.
    View in: PubMed
    Score: 0.004
  22. Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. Cell Metab. 2018 May 01; 27(5):977-987.e4.
    View in: PubMed
    Score: 0.004
  23. SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents. Cancer Res. 2016 09 15; 76(18):5467-78.
    View in: PubMed
    Score: 0.004
  24. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
    View in: PubMed
    Score: 0.004
  25. Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation. Mol Cancer Ther. 2015 Mar; 14(3):788-98.
    View in: PubMed
    Score: 0.003
  26. Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis. PLoS One. 2014; 9(7):e101452.
    View in: PubMed
    Score: 0.003
  27. Interleukin-1? promotes ovarian tumorigenesis through a p53/NF-?B-mediated inflammatory response in stromal fibroblasts. Neoplasia. 2013 Apr; 15(4):409-20.
    View in: PubMed
    Score: 0.003
  28. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol. 2006 Dec 18; 175(6):913-23.
    View in: PubMed
    Score: 0.002
  29. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res. 2005 Dec 15; 65(24):11510-9.
    View in: PubMed
    Score: 0.002
  30. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res. 2005 Dec 15; 65(24):11658-66.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.